UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.512

Sortiert nach

Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study

Nature medicine, 2020-11, Vol.26 (11), p.1720-1725

2020

Link zum Volltext

Verfügbarkeit prüfen

Special Issue "Advances in Molecular Pathogenesis and Targeted Therapies for Myeloid Neoplasms"

International journal of molecular sciences, 2024-02, Vol.25 (4), p.2056

2024

Link zum Volltext

Verfügbarkeit prüfen

RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL)

PLoS genetics, 2022-10, Vol.18 (10), p.e1010300-e1010300

2022

Link zum Volltext

Verfügbarkeit prüfen

The acquisition order of leukemic drug resistance mutations is directed by the selective fitness associated with each resistance mechanism

Scientific reports, 2023-08, Vol.13 (1), p.13110-13110, Article 13110

2023

Link zum Volltext

Verfügbarkeit prüfen

Gain of chromosome 21 increases the propensity for P2RY8: :CRLF2 acute lymphoblastic leukemia via increased HMGN1 expression

Frontiers in oncology, 2023-07, Vol.13, p.1177871-1177871

2023

Link zum Volltext

Verfügbarkeit prüfen

A comprehensive evaluation of the efficacy of leading oxime therapies in guinea pigs exposed to organophosphorus chemical warfare agents or pesticides

Toxicology and applied pharmacology, 2014-12, Vol.281 (3), p.254-265

2014

Link zum Volltext

Verfügbarkeit prüfen

BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia

Haematologica (Roma), 2018-12, Vol.103 (12), p.2026-2032

2018

Link zum Volltext

Verfügbarkeit prüfen

Toxicity and median effective doses of oxime therapies against percutaneous organophosphorus pesticide and nerve agent challenges in the Hartley guinea pig

The Journal of Toxicological Sciences, 2016/08/01, Vol.41(4), pp.511-521

2016

Link zum Volltext

Verfügbarkeit prüfen

DUX Hunting—Clinical Features and Diagnostic Challenges Associated with DUX4-Rearranged Leukaemia

Cancers, 2020-10, Vol.12 (10), p.2815

2020

Link zum Volltext

Verfügbarkeit prüfen

Case Report: Precision Medicine Target Revealed by In Vitro Modeling of Relapsed, Refractory Acute Lymphoblastic Leukemia From a Child With Neurofibromatosis

Frontiers in oncology, 2022-04, Vol.12, p.851572

2022

Link zum Volltext

Verfügbarkeit prüfen

Supporting discovery and development of medical countermeasures for chemical injury to eye and skin

Experimental eye research, 2022-08, Vol.221, p.109156-109156, Article 109156

2022

Link zum Volltext

Verfügbarkeit prüfen

Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients

Cancers, 2023-09, Vol.15 (19), p.4731

2023

Link zum Volltext

Verfügbarkeit prüfen

JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies

Frontiers in cell and developmental biology, 2022-07, Vol.10, p.942053-942053

2022

Link zum Volltext

Verfügbarkeit prüfen

Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemia

NPJ precision oncology, 2021-08, Vol.5 (1), p.1-13, Article 75

2021

Link zum Volltext

Verfügbarkeit prüfen

Asciminib: a new therapeutic option in chronic-phase CML with treatment failure

Blood, 2022-06, Vol.139 (24), p.3474-3479

2022

Link zum Volltext

Verfügbarkeit prüfen

Elements of successful NIH grant applications

Proceedings of the National Academy of Sciences - PNAS, 2024-04, Vol.121 (15), p.e2315735121

2024

Link zum Volltext

Verfügbarkeit prüfen

Autologous Faecal Microbiota Transplantation to Improve Outcomes of Haematopoietic Stem Cell Transplantation: Results of a Single-Centre Feasibility Study

Biomedicines, 2023-12, Vol.11 (12), p.3274

2023

Link zum Volltext

Verfügbarkeit prüfen

Compound mutations in CML—imaginary bogeyman or real arch-nemesis?

Leukemia research, 2019-06, Vol.81, p.102-104

Yeung, David T.

2019

Link zum Volltext

Verfügbarkeit prüfen

Polycomb Factor PHF19 Controls Cell Growth and Differentiation Toward Erythroid Pathway in Chronic Myeloid Leukemia Cells

Frontiers in cell and developmental biology, 2021-04, Vol.9, p.655201-655201

2021

Link zum Volltext

Verfügbarkeit prüfen

Assessing the therapeutic efficacy of oxime therapies against percutaneous organophosphorus pesticide and nerve agent challenges in the Hartley guinea pig

The Journal of Toxicological Sciences, 2015/12/01, Vol.40(6), pp.759-775

2015

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study

Blood, 2013-07, Vol.122 (4), p.515-522

2013

Link zum Volltext

Verfügbarkeit prüfen

B‐cell acute lymphoblastic leukaemia: recent discoveries in molecular pathology, their prognostic significance, and a review of the current classification

British journal of haematology, 2022-04, Vol.197 (1), p.13-27

2022

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Storage Stability of Diisopropylfluorophosphate

Journal of chemistry, 2016-01, Vol.2016, p.1-5

2016

Link zum Volltext

Verfügbarkeit prüfen

Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemia

Blood, 2021-03, Vol.137 (9), p.1196-1207

2021

Link zum Volltext

Verfügbarkeit prüfen

Successful treatment‐free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells

British journal of haematology, 2020-11, Vol.191 (3), p.433-441

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.512

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.143)
Mit Volltextzugriff
(2.286)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.507)
Life Sciences & Biomedicine
(1.214)
Humans
(961)
Female
(546)
Male
(524)
Middle Aged
(322)
Adult
(296)
Biological And Medical Sciences
(247)
Aged
(238)
Medical Sciences
(205)
Animals
(204)
Physical Sciences
(161)
Technology
(157)
Oncology
(128)
Adolescent
(121)
Treatment Outcome
(121)
Patients
(110)
Cardiovascular System & Cardiology
(104)
Social Sciences
(103)
Surgery
(103)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(99)
Journal Of Clinical Oncology
(40)
Plos One
(34)
Journal Of The American College Of Cardiology
(30)
Circulation
(29)
Scientific Reports
(21)
Journal Of Diabetes Science And Technology
(20)
Journal Of Magnetic Resonance Imaging
(19)
Cancer Research
(18)
Arthritis & Rheumatology
(16)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(20)
... seit 90 Tagen
(42)

Menü

Weitere Dienste

Einstellungen

Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study

Special Issue "Advances in Molecular Pathogenesis and Targeted Therapies for Myeloid Neoplasms"

RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL)

The acquisition order of leukemic drug resistance mutations is directed by the selective fitness associated with each resistance mechanism

Gain of chromosome 21 increases the propensity for P2RY8: :CRLF2 acute lymphoblastic leukemia via increased HMGN1 expression

A comprehensive evaluation of the efficacy of leading oxime therapies in guinea pigs exposed to organophosphorus chemical warfare agents or pesticides

BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia

Toxicity and median effective doses of oxime therapies against percutaneous organophosphorus pesticide and nerve agent challenges in the Hartley guinea pig

DUX Hunting—Clinical Features and Diagnostic Challenges Associated with DUX4-Rearranged Leukaemia

Case Report: Precision Medicine Target Revealed by In Vitro Modeling of Relapsed, Refractory Acute Lymphoblastic Leukemia From a Child With Neurofibromatosis

Supporting discovery and development of medical countermeasures for chemical injury to eye and skin

Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients

JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies

Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemia

Asciminib: a new therapeutic option in chronic-phase CML with treatment failure

Elements of successful NIH grant applications

Autologous Faecal Microbiota Transplantation to Improve Outcomes of Haematopoietic Stem Cell Transplantation: Results of a Single-Centre Feasibility Study

Compound mutations in CML—imaginary bogeyman or real arch-nemesis?

Polycomb Factor PHF19 Controls Cell Growth and Differentiation Toward Erythroid Pathway in Chronic Myeloid Leukemia Cells

Assessing the therapeutic efficacy of oxime therapies against percutaneous organophosphorus pesticide and nerve agent challenges in the Hartley guinea pig

Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study

B‐cell acute lymphoblastic leukaemia: recent discoveries in molecular pathology, their prognostic significance, and a review of the current classification

Synthesis and Storage Stability of Diisopropylfluorophosphate

Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemia

Successful treatment‐free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells

Suchergebnisse filtern